company background image
300573 logo

Shenyang Xingqi PharmaceuticalLtd XSEC:300573 Stock Report

Last Price

CN¥78.88

Market Cap

CN¥13.8b

7D

0.8%

1Y

-60.6%

Updated

20 May, 2025

Data

Company Financials

Shenyang Xingqi Pharmaceutical Co.,Ltd.

XSEC:300573 Stock Report

Market Cap: CN¥13.8b

300573 Stock Overview

Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China. More details

300573 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends3/6

Rewards

Price-To-Earnings ratio (30.8x) is below the CN market (38.2x)

Earnings grew by 75.9% over the past year

Risk Analysis

Unstable dividend track record


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Shenyang Xingqi Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Shenyang Xingqi PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥78.88
52 Week HighCN¥214.36
52 Week LowCN¥64.88
Beta0.54
1 Month Change9.63%
3 Month Change6.88%
1 Year Change-60.58%
3 Year Change28.96%
5 Year Changen/a
Change since IPO12.20%

Recent News & Updates

Recent updates

Shareholder Returns

300573CN PharmaceuticalsCN Market
7D0.8%3.7%0.3%
1Y-60.6%3.2%8.5%

Return vs Industry: 300573 underperformed the CN Pharmaceuticals industry which returned 0.7% over the past year.

Return vs Market: 300573 underperformed the CN Market which returned 7.2% over the past year.

Price Volatility

Is 300573's price volatile compared to industry and market?
300573 volatility
300573 Average Weekly Movement7.0%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement7.0%
10% most volatile stocks in CN Market10.3%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 300573 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300573's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19772,426E. Gaowww.sinqi.com

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China. The company develops ophthalmic anti-infective drugs, other ophthalmic drugs, nonsteroidal anti-inflammatory drugs for ophthalmology, mydriatic and ciliary muscle paralytic drugs, ophthalmic anti-inflammatory/anti-infective compound drugs, dry eye products, miotic and anti-glaucoma drugs, and other drugs.

Shenyang Xingqi Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Shenyang Xingqi PharmaceuticalLtd's earnings and revenue compare to its market cap?
300573 fundamental statistics
Market capCN¥13.82b
Earnings (TTM)CN¥449.21m
Revenue (TTM)CN¥2.13b
30.8x
P/E Ratio
6.5x
P/S Ratio

Is 300573 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300573 income statement (TTM)
RevenueCN¥2.13b
Cost of RevenueCN¥447.31m
Gross ProfitCN¥1.68b
Other ExpensesCN¥1.23b
EarningsCN¥449.21m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)2.56
Gross Margin79.00%
Net Profit Margin21.09%
Debt/Equity Ratio10.3%

How did 300573 perform over the long term?

See historical performance and comparison

Dividends

1.9%
Current Dividend Yield
58%
Payout Ratio

Does 300573 pay a reliable dividends?

See 300573 dividend history and benchmarks
When do you need to buy 300573 by to receive an upcoming dividend?
Shenyang Xingqi PharmaceuticalLtd dividend dates
Ex Dividend DateMay 22 2025
Dividend Pay DateMay 22 2025
Days until Ex dividend1 day
Days until Dividend pay date1 day

Does 300573 pay a reliable dividends?

See 300573 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 06:55
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shenyang Xingqi Pharmaceutical Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tielin ChenTopsperity Securities
Jing ChenTopsperity Securities